A B S T R A C T After intravenous administration of radiolabeled 1,25-dihydroxyvitamnin D3 to rats, -25% of the administered radioactivity appeared in the bile within 24 h. Instillation of the biliary radioactivity into the duodena of other rats was followed by recovery of 15% of the radioactivity in newly secreted bile within 24 h. The process by which products of 1,25-dihydroxyvitamin D3 were excreted in bile was not saturable in the dose range tested (0.275-650 ng). The metabolites of 1,25-dihydroxyvitamin D3 present in bile were found to be much more polar than 1,25-dihydroxyvitamin D3 and were resolved into three fractions on high performanice liquid chromatography. 60% of the radioactivity present in bile was retained selectively by DEAE-cellulose; the radioactive material could be eluted from the gel at a low pH or at high salt concentrations. When bile containing the radiolabeled metabolites was incubated at 37°C and pH 5 with f3-glucuronidase, there was an increase in the amount of radioactivity comigrating with 1,25-dihydroxyvitamin D3. Treatment of the products of radiolabeled 1,25-dihydroxyvitamin D3 in bile with diazomethane, an agent which converts acids into methyl esters, transformed one of the metabolites into a less polar compound. These results demonstrate that there is a quantitatively important enterohepatic circulation of the products of 1,25-dihydroxyvitamin D3 in the rat.
INTRODUCTION
Metabolites of vitamin D3 and 25-hydroxyvitamin D3 appear in the bile after administration of these radiolabeled vitamins to man or to the rat (1-3). Furthermore, the metabolites are more polar than the administered compounds (2, 3) . It is suspected that these more polar compounds are glucuronides, or other conjugates of the parent sterol, since treatment with p-glucuronidase results in a decrease in polarity of the biliary metabolites (1-3).
1,25-dihydroxyvitamin D3 is presently thought to be the active form of vitamin D and is known to be metabolized by side chain oxidation and 24-hydroxylation in the intestine and kidney (4) (5) (6) (7) (8) (9) . However, these processes account for only part of the metabolism of 1,25-dihydroxvvitamin D3. A large fraction of the radioactivity is known to appear in the feces of both rat (unpublished observations) and man (10) after the intravenous administrationi of radiolabeled 1,25-dihydroxyvitamin D3; these findings suggest that biliary exeretioin and possibly enterohepatic circulation of 1,25-dihydroxyvitamin D3 may occur. The present studies were carried out to determiine whether there was biliary excretion and enterohepatic circulation of 1,25-dihydroxyvitamin D3, and if so, to partially characterize the metabolites excreted in bile.
METHODS

Aiiials
1-d-old white leghorn cockerels (Rochester Chicken Feed Supply, Rochester, Minn.) were raised on a 1% calcium rachitogenic diet and sacrificed when 6 wk old to provide a source for renal mitochondria (11) .
Male rats (200-210 g) were obtained from the Holtzman Co., (Madison, Wis.) and maintained on rat chow that contained 1.2% calcium, 0.86% phosphorus, and adequate amounts of vitamin D (5.31 IU/g feed). Experiments were conducted when the weight of the animals was between 200-220 g.
Anesthesia and surgery
Immediately before surgery, the rats were anaesthetized with sodium pentobarbital (30 mg/kg). A midline laparotomy incision was made, the bile duct was catheterized with polyethylene tubing, the tube was exteriorized, and the abdomen was closed with suture and metal clips. Immediately thereafter, the rats were injected intrajugularly with radiolabeled 1,25-dihydroxyvitamin D3 and all bile was collected for 24 h.
In studies designed to detect the presence of an enterohepatic circulation of 1,25-dihydroxyvitamin D3 metabolites, the bile ducts were catheterized in the manner described above. A small incision was made in the distal duodenum into which radiolabeled bile (-0.5 ml) obtained in the above experiments was instilled with a syringe. The duodenal and abdominal incisions were then closed with suture, and bile was collected for 24 h. In some instances blood was collected immediately before termination of the experiment to test for the presence of circulating radioactivity.
Synthetic and radiolabeled compounds Synthetic 1,25-dihydroxyvitamin D3 was kindly donated by Dr. M. Uskokovic of Hoffman-LaRoche, Inc., Nutley, N. J.
[23,24-3H]25-hydroxyvitamin D3 (110 Ci/mmol) and [26,27-3H]25-hydroxyvitamin D3 (9 Ci/mmol) were obtained from the Amersham Corp. (Arlington Heights, Ill.). These compounds were hydroxylated enzymatically to give radiolabeled 1,25-dihydroxyvitamin D3 by using kidney mitochondria from rachitic chicks (11) . Radiochemical purity of each product was established by cochromatography with authentic 1,25-dihydroxyvitamin D3 on high performance liquid chromatography. All radiolabeled materials were more than 98% pure by chromatography. To test the purity of the radiolabeled 1,25-dihydroxyvitamin D3, 2000 cpm of the compound was mixed with 500 ng of authentic, nonradiolabeled 1,25-dihydroxyvitamin D3 and chromatographed on a 0.4 x 30-cm column of ,uPorasil with 10 ,um silica (Waters Associates), using 90:10 (vol/vol) n-hexane/2-propanol as the solvent system at a flow rate of 2 ml/min and a pressure of about 600 lb/in.2. Radioactive 1,25-dihydroxyvitamin D3 co-eluted with synthetic 1,25-dihydroxyvitamin D3 in this system.
To determine the chromatographic mobility of the radioactive biliary metabolites of 1,25-dihydroxyvitamin D3, an aliquot of bile (2000 dpm) to which 1 ,.tg of cold 1,25-dihydroxyvitamin D3 had been added was dried and resuspended in 100 ,ul of 50:50 (vol/vol) methanol/water and applied to a C-18 ,Bondapak column (Waters Associates). A linear gradient from 50% methanol/water to 100% methanol was developed over 35-40 min. The flow rate was 2 ml/min. Starting pressure (50% methanol/water) was 2,200 lb/in.2; final pressure was 600 lb/in.2 (100% methanol); 2-ml (1 mi) aliquots were collected. In other experiments, bile was treated with /8-glucuronidase at pH 5, with buffer at pH 5 or with water alone for 16-24 h as described below. The reaction mixture was extracted three times with chloroform. The chloroform layers were combined and dried. The residue was resuspended in 300 ,l 50:50 (vol/vol) methanol/water that contained 1 ,tg 1,25-dihydroxyvitamin D3 and applied to the described high performance system. Alternatively, the reaction mixture was dried, resuspended in column solvent that contained 1 jig 1,25-dihydroxyvitamin D3, and directly applied to the high performance system described. In both cases an aliquot of the sample was taken for determination of radioactivity.
Silicic acid chromatographt . Aliquots of bile, 0.5-1.0 ml, obtained after the injection of radiolabeled 1,25-dihydroxyvitamin D3 into rats, were chromatographed onl a 10g, 1 x 30-cm silicic acid columni (Bio-Sil A, 100-200 mesh, BioRad Laboratories, Richmond, Calif.). The bile was applied by mixing it with -0.5 g of dry silicic acid and applying it directly to the column. The column was developed successively with 100 ml of hexane, 100 ml of ethyl acetate, 250 ml of methanol, and 150 ml of 50:50 (vol/vol) (12, 13) was incubated with sodium acetate at pH 5, with sodium acetate at pH 5 plus 1,500 U 3-glucuronidase (type B-10) and with sodium acetate at pH 5 plus 150 u1 of bile obtained from a normal rat that received no 1,25-dihydroxyvitamin D3.
Treatment ofbile with diazomethane. Aliquots ofcrude or partially purified bile (1 Ml) were dried in vacuo, redissolved in 95% methanol (1 ml), and treated with an excess of freshly prepared diazomethane (0.96 mM) in ether. After 10 min at room temperature, the excess ofdiazomethane was distilled off or decomposed by the addition of 3-5% acetic acid in methanol. The reaction mixture was concentrated in vacuo and the residue was subjected to DEAE batch chromatography as described or to paper chromatography. 1 
RESULTS
In the present studies, 11.3±+1.5% (mean±+SD) of the radioactivity from the [23,24-3H] 1,25-dihydroxyvitamin D3 injected, appeared in the bile within 1 h (Fig. 1) . At 3 h, the amount of radioactivity excreted was 17.6+1.12% and at 24 h the amount was 24.7+3.4%. There was a linear relationship at each sampling time between the amount of radioactivity excreted in bile and the dose of [23,24-3H] 1,25-dihydroxyvitamin D3 administered (Fig. 2) .
The radioactivity recovered from bile after the intravenous injection of [3H] 1,25-dihydroxyvitamin D3 was instilled into the duodena of other rats; the amount of radioactivity subsequently recovered in newly excreted bile is shown in Fig. 3 . Approximately 7, 12, and 15% of the radioactivity instilled into the duodenum was recovered from newly excreted bile at 2, 6, and 24 h, respectively. Chromatography of bile on Lipidex 5000 revealed that biliary radioactivity derived from 1,25-dihydroxyvitamin D3 was eluted as a more polar peak (Fig.  4) . Similarly, silicic acid chromatography demonstrated that -85-90% of the radioactivity was present as a polar radioactive peak that eluted at about fraction 42 with 100% methanol (Fig. 5) . Approximately 10% of the radioactivity was present as a nonpolar metabolite that co-eluted with 1,25-dihydroxyvitamin D3. The profile of radioactivity from high performance liquid chromatography of bile from rats injected with radiolabeled 1,25-dihydroxyvitamin D3 is shown in Fig. 6 . A small percentage of the radioactivity (-5%) was present as 1,25-dihydroxyvitamin D3, but most of the radioactivity was present as three polar peaks.
The effect of various types of treatment on the chloroform solubility of radioactivity from the bile of rats that had received radiolabeled 1,25-dihydroxyvitamin D3 is presented in Table II at pH 5 or with water alone, was carried out before high performance liquid chromatography, the amount of radioactivity comigrating with 1,25-dihydroxyvitamin D3 was 10.3, 6.2, and 3.7% of the total radioactivity in the reaction mixture, respectively. The remaining radioactivity present in the chloroform extracts was in the form of other more polar peaks. When the reaction mixture was dried and applied to the high performance liquid chromatography system without prior chloroform extraction, the amount of radioactivity comigrating with 1,25-dihydroxyvitamin D3 after treatment with f8-glucuronidase, with buffer at pH 5, or with water alone was 15.7±7.6, 6.7+3.4, and 5.7 ±0.3% of the total radioactivity in the reaction mixture, respectively (Table III) . To Table IV . It is apparent that bile contains /8-glucuronidase activity.
60-70% of the radioactivity excreted in the bile was selectively retained by DEAE-cellulose in the pres- ence of methanol. The radioactivity could be eluted from the gel by adding acid or salt to the eluting solvent (methanol). Three radioactive peaks were eluted with increasing amounts of acetic acid in the methanol (Fig.  7) . Treatment of the bile with diazomethane, a compound which esterifies acids, resulted in a decrease in polarity of one metabolite as assessed by paper chromatography. After treatment with diazomethane, 44% of the radioactivity of bile was present as nonpolar material (Rf > 0.8) on paper chromatography, whereas only 28% of the radioactivity was present in bile as nonpolar material before treatment with diazomethane. After treatment with diazomethane, 56±15% (mean ±SD) of the total radioactivity applied to DEAE cellulose was eluted with methanol alone; before treatment with diazomethane 12±4% of the radioactivity applied to DEAE cellulose was eluted with methanol.
DISCUSSION
The present studies demonstrate that the excretion of products of 1,25-dihydroxyvitamin D3 in bile occurs within 30 min of the injection of radiolabeled 1,25-dihydroxyvitamin D3; 25% of an injected dose appears in bile within 24 h. A considerable portion of the radioactivity found in bile and instilled into the duodena of other rats, was subsequently absorbed from the intestine and reexcreted in newly formed bile. Thus, there is a quantitatively important enterohepatic circulation of metabolites of 1,25-dihydroxyvitamin D3 in the rat. The liver appears to have the capacity to excrete increasing amounts of these metabolites in bile, even when pharmacological doses of the compound are administered intravenously. The excretory process is not saturable in the dose range tested (0.275-650 ng). The present findings may be of importance in elucidating the pathogenesis of hepatic osteodystrophy in man. It is thought that defects in vitamin D metabolism are responsible for hepatic osteodystrophy (14) . It seems possible that the reabsorption of metabolites of vitamin D3 from the intestine may be altered in conditions such as coeliac disease, or that fecal excretion may be enhanced in conditions such as primary biliary Enterohepatic Physiology of 1,25-dihydroxyvitamin D3 cirrhosis. A study ofthese defects, ifpresent, must await a description of the enterohepatic physiology of 1,25-dihydroxyvitamin D3 in man.
